Actively Recruiting
Phase IbII Study of IAP0971 Treatment for Adults Aged 18 to 75 with Advanced Malignant Tumors
Led by SUNHO（China）BioPharmaceutical CO., Ltd. · Updated on 2024-02-20
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating IAP0971 in patients with advanced malignant tumors in this Phase IbII clinical trial. The study aims to assess the safety, tolerability, and early effectiveness of IAP0971 in patients whose cancers have progressed despite standard treatments or who have limited treatment options. The trial is sponsored by SUNHO China BioPharmaceutical CO., Ltd. and focuses on solid tumors including advanced non-small cell lung cancer NSCLC.
CONDITIONS
Brief Title
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
